Novo Integrated Sciences Stock Alpha and Beta Analysis
| NVOS Stock | USD 0 0 440.00% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Novo Integrated Sciences. It also helps investors analyze the systematic and unsystematic risks associated with investing in Novo Integrated over a specified time horizon. Remember, high Novo Integrated's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Novo Integrated's market risk premium analysis include:
Beta 33.56 | Alpha 46.87 | Risk 191.32 | Sharpe Ratio 0.26 | Expected Return 50.06 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out Novo Integrated Backtesting, Novo Integrated Valuation, Novo Integrated Correlation, Novo Integrated Hype Analysis, Novo Integrated Volatility, Novo Integrated History and analyze Novo Integrated Performance. Novo Integrated Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Novo Integrated market risk premium is the additional return an investor will receive from holding Novo Integrated long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Novo Integrated. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Novo Integrated's performance over market.| α | 46.87 | β | 33.56 |
Novo Integrated expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Novo Integrated's Buy-and-hold return. Our buy-and-hold chart shows how Novo Integrated performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Novo Integrated Market Price Analysis
Market price analysis indicators help investors to evaluate how Novo Integrated stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Novo Integrated shares will generate the highest return on investment. By understating and applying Novo Integrated stock market price indicators, traders can identify Novo Integrated position entry and exit signals to maximize returns.
Novo Integrated Return and Market Media
The median price of Novo Integrated for the period between Thu, Oct 2, 2025 and Wed, Dec 31, 2025 is 0.005 with a coefficient of variation of 156.08. The daily time series for the period is distributed with a sample standard deviation of 0.01, arithmetic mean of 0.0, and mean deviation of 0.0. The Stock received some media coverage during the period. Price Growth (%) |
| Timeline |
1 | Disposition of 19800 shares by Flesias Alex of Novo Integrated at 3.8 subject to Rule 16b-3 | 10/28/2025 |
2 | Disposition of 100 shares by Rouse Michael of Novo Integrated at 1.78 subject to Rule 16b-3 | 11/19/2025 |
3 | Acquisition by Ali Sarfaraz of 480 shares of Novo Integrated subject to Rule 16b-3 | 11/27/2025 |
4 | Acquisition by Christopher David of 2000000 shares of Novo Integrated at 0.132 subject to Rule 16b-3 | 12/05/2025 |
About Novo Integrated Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Novo or other stocks. Alpha measures the amount that position in Novo Integrated Sciences has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2021 | 2022 | 2023 | 2025 (projected) | Interest Debt Per Share | 7.06 | 0.94 | 0.23 | 32.29 | Revenue Per Share | 4.03 | 1.24 | 0.74 | 33.7 |
Novo Integrated Upcoming Company Events
As portrayed in its financial statements, the presentation of Novo Integrated's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Novo Integrated's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Novo Integrated's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Novo Integrated. Please utilize our Beneish M Score to check the likelihood of Novo Integrated's management manipulating its earnings.
| 24th of May 2024 Upcoming Quarterly Report | View | |
| 29th of February 2024 Next Fiscal Quarter End | View |
Build Portfolio with Novo Integrated
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for Novo Stock Analysis
When running Novo Integrated's price analysis, check to measure Novo Integrated's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novo Integrated is operating at the current time. Most of Novo Integrated's value examination focuses on studying past and present price action to predict the probability of Novo Integrated's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novo Integrated's price. Additionally, you may evaluate how the addition of Novo Integrated to your portfolios can decrease your overall portfolio volatility.